Vikas Lifecare Crecimiento futuro

Future controles de criterios 0/6

Actualmente no disponemos de suficiente cobertura de analistas para prever el crecimiento y los ingresos de Vikas Lifecare.

Información clave

n/a

Tasa de crecimiento de los beneficios

n/a

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Trade Distributors	6.8%
Tasa de crecimiento de los ingresos	n/a
Rentabilidad financiera futura	n/a
Cobertura de analistas	None
Última actualización	n/a

Actualizaciones recientes sobre el crecimiento futuro

No hay actualizaciones

Recent updates

We Think You Should Be Aware Of Some Concerning Factors In Vikas Lifecare's (NSE:VIKASLIFE) Earnings

Jun 07

Further Upside For Vikas Lifecare Limited (NSE:VIKASLIFE) Shares Could Introduce Price Risks After 33% Bounce

Jan 09

Returns At Vikas Lifecare (NSE:VIKASLIFE) Are On The Way Up

Oct 26

Vikas Lifecare (NSE:VIKASLIFE) Seems To Use Debt Quite Sensibly

Sep 15

Some Investors May Be Worried About Vikas Lifecare's (NSE:VIKASLIFE) Returns On Capital

Jun 15

Investors Who Bought Vikas Multicorp (NSE:VIKASMCORP) Shares A Year Ago Are Now Up 130%

Dec 08

Have Vikas Multicorp Limited (NSE:VIKASMCORP) Insiders Been Selling Their Stock?

Nov 01

Have Vikas Multicorp Limited (NSE:VIKASMCORP) Insiders Been Selling Their Stock?

Oct 06

Here's Why Vikas Multicorp (NSE:VIKASMCORP) Is Weighed Down By Its Debt Load

Oct 01

How Much Of Vikas Multicorp Limited (NSE:VIKASMCORP) Do Insiders Own?

Aug 26

If You Had Bought Vikas Multicorp (NSE:VIKASMCORP) Shares A Year Ago You'd Have Earned181% Returns

Jul 31

Vikas Multicorp Limited's (NSE:VIKASMCORP) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Jul 02

En esta sección solemos presentar previsiones de crecimiento de ingresos y beneficios basadas en las estimaciones por consenso de analistas profesionales para ayudar a los inversores a comprender la capacidad de la empresa para generar beneficios. Pero como Vikas Lifecare no ha proporcionado suficientes datos anteriores y no dispone de previsiones de analistas, sus beneficios futuros no pueden calcularse de forma fiable extrapolando datos anteriores o utilizando las previsiones de los analistas.

Es una situación poco común, ya que el 97% de las empresas disponibles en SimplyWall St sí disponen de datos financieros anteriores.

Previsiones de crecimiento de beneficios e ingresos

NSEI:VIKASLIFE - Estimaciones futuras de los analistas y datos financieros pasados (INR Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
9/30/2024	4,578	-62	-2,033	-1,803	N/A
6/30/2024	4,389	-8	N/A	N/A	N/A
3/31/2024	4,457	140	-577	-417	N/A
12/31/2023	4,323	-111	N/A	N/A	N/A
9/30/2023	4,670	-11	-863	-1,093	N/A
6/30/2023	4,827	-58	N/A	N/A	N/A
3/31/2023	4,760	-153	-1,300	-1,122	N/A
12/31/2022	4,605	346	N/A	N/A	N/A
9/30/2022	4,333	309	-767	-246	N/A
6/30/2022	3,690	310	N/A	N/A	N/A
3/31/2022	3,009	287	-266	-149	N/A
12/31/2021	2,284	17	N/A	N/A	N/A
9/30/2021	1,311	-11	N/A	N/A	N/A
6/30/2021	954	-32	N/A	N/A	N/A
3/31/2021	750	-35	-92	-77	N/A
12/31/2020	792	0	N/A	N/A	N/A
9/30/2020	1,169	11	N/A	N/A	N/A
6/30/2020	1,360	14	N/A	N/A	N/A
3/31/2020	1,562	14	30	35	N/A
3/31/2019	2,169	21	-125	-116	N/A
3/31/2018	1,954	15	N/A	-232	N/A
3/31/2017	1,008	7	N/A	N/A	N/A
3/31/2016	937	7	N/A	N/A	N/A
3/31/2015	811	4	N/A	N/A	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Datos insuficientes para determinar si el crecimiento previsto de los beneficios de VIKASLIFE es superior a la tasa de ahorro (6.7%).

Beneficios vs. Mercado: Datos insuficientes para determinar si se prevé que los beneficios de VIKASLIFE crezcan más rápidamente que el mercado Indian

Beneficios de alto crecimiento: Datos insuficientes para determinar si se espera que los beneficios de VIKASLIFE crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: No hay datos suficientes para determinar si se prevé que los ingresos de VIKASLIFE crezcan más rápidamente que el mercado de Indian.

Ingresos de alto crecimiento: No hay datos suficientes para determinar si se prevé que los ingresos de VIKASLIFE crezcan a un ritmo superior a 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de VIKASLIFE se prevé que sea elevada dentro de 3 años.

Vikas Lifecare Crecimiento futuro

Future controles de criterios 0/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

New major risk - Revenue and earnings growth

Second quarter 2025 earnings released: EPS: ₹0.03 (vs ₹0.06 in 2Q 2024)

Vikas Lifecare Limited to Report Q2, 2025 Results on Oct 22, 2024

New minor risk - Market cap size

Vikas Lifecare Limited, Annual General Meeting, Sep 29, 2024

First quarter 2025 earnings released

Vikas Lifecare Limited to Report Q1, 2025 Results on Jul 20, 2024

Investor sentiment improves as stock rises 17%

A Consortium including Vikas Lifecare Limited (NSEI:VIKASLIFE) made a bid to acquire Ebix, Inc. (OTCPK:EBIX.Q).

We Think You Should Be Aware Of Some Concerning Factors In Vikas Lifecare's (NSE:VIKASLIFE) Earnings

Full year 2024 earnings released: EPS: ₹0.09 (vs ₹0.12 loss in FY 2023)

Vikas Lifecare Limited Approves Executive Changes

Vikas Lifecare Limited to Report Q4, 2024 Results on May 29, 2024

Vikas Lifecare Limited Appoints Sanjay Kumar Jaiswal as Compliance Officer

Vikas Lifecare Limited announced that it has received INR 242.5 million in funding from Sylph Technologies Limited, Srestha Finvest Limited

Third quarter 2024 earnings released: ₹0.03 loss per share (vs ₹0.05 profit in 3Q 2023)

Vikas Lifecare Limited to Report Q3, 2024 Results on Feb 13, 2024

Vikas Lifecare Limited Announces CEO Changes

Less than half of directors are independent

Vikas Lifecare Limited Announces Resignation of Ruby Bansal as Non-Executive Independent Director

Further Upside For Vikas Lifecare Limited (NSE:VIKASLIFE) Shares Could Introduce Price Risks After 33% Bounce

Returns At Vikas Lifecare (NSE:VIKASLIFE) Are On The Way Up

Second quarter 2024 earnings released: EPS: ₹0.06 (vs ₹0.018 in 2Q 2023)

Vikas Lifecare Limited to Report Q2, 2024 Results on Oct 17, 2023

Vikas Lifecare (NSE:VIKASLIFE) Seems To Use Debt Quite Sensibly

New minor risk - Share price stability

Vikas Lifecare Limited (NSEI:VIKASLIFE) acquired 98% stake in MSR Apparels Private Limited for INR 125 million.

First quarter 2024 earnings released: EPS: ₹0.08 (vs ₹0.022 in 1Q 2023)

Vikas Lifecare Limited, Annual General Meeting, Sep 27, 2023

Vikas Lifecare Limited to Report Q1, 2024 Results on Aug 12, 2023

Some Investors May Be Worried About Vikas Lifecare's (NSE:VIKASLIFE) Returns On Capital

Vikas Lifecare Limited Announces Appointment of Chandan Kumar as Director (Finance) Cum Chief Financial Officer

Full year 2023 earnings released: ₹0.11 loss per share (vs ₹0.31 profit in FY 2022)

Third quarter 2023 earnings released: EPS: ₹0.05 (vs ₹0.03 in 3Q 2022)

Vikas Lifecare Limited Announces Appointment of Mr. Balwant Kumar Bhushan as an Additional Director

Vikas Lifecare Limited to Report Q3, 2023 Results on Jan 25, 2023

Investor sentiment deteriorated over the past week

High number of new and inexperienced directors

Second quarter 2023 earnings released: EPS: ₹0.018 (vs ₹0.029 in 2Q 2022)

Vikas Lifecare Limited to Report Q2, 2023 Results on Oct 21, 2022

Vikas Lifecare Limited (BSE:542655) acquired 30% stake in Ardh Sainik Canteen Limited from its existing stakeholders for INR 150 million.

Vikas Lifecare Limited Approves Appointment of Mr. Chandan Kumar as A Director of Company

Investor sentiment deteriorated over the past week

Vikas Lifecare Limited, Annual General Meeting, Sep 29, 2022

Vikas Lifecare Limited has completed a Follow-on Equity Offering in the amount of INR 499.999997 million.

First quarter 2023 earnings released: EPS: ₹0.23 (vs ₹0.004 in 1Q 2022)

Vikas Lifecare Limited Announces Addition of 'Almonds and Walnuts' to Company's Agro-Products Division Offerings

Vikas Lifecare Limited has completed a Follow-on Equity Offering in the amount of INR 500 million.

Vikas Lifecare's (NSE:VIKASLIFE) Earnings Aren't As Good As They Appear

Full year 2022 earnings released: EPS: ₹0.31 (vs ₹0.053 loss in FY 2021)

Vikas Lifecare Limited to Report Q4, 2022 Results on May 28, 2022

High number of new and inexperienced directors

Vikas Lifecare Limited (BSE:542655) agreed to acquire a 75% stake in Genesis Gas Solutions Private Limited for CAD 250 million.

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Vikas Lifecare's (NSE:VIKASLIFE) Returns Have Hit A Wall

We Think Vikas Lifecare (NSE:VIKASLIFE) Is Taking Some Risk With Its Debt

Second quarter 2022 earnings released

Independent Director Meena Bansal has left the company

Chief Financial Officer Chandan Bhardwaj has left the company

Independent & Non-Executive Director Pankaj Gupta has left the company

Independent & Non-Executive Director Pankaj Gupta has left the company

Non-Executive Director recently sold ₹20m worth of stock

Non-Executive Director recently sold ₹67m worth of stock

Vikas Lifecare Limited (BSE:542655) agreed to acquire Hydrolina Biotec Private Limited.

Vikas Multicorp Limited (BSE:542655) completed the acquisition of an unknown stake in Advik Laboratories Limited (BSE:531686) from Advik's promoters.

Full year 2021 earnings released: ₹0.05 loss per share (vs ₹0.021 profit in FY 2020)

Vikas Lifecare Limited has completed a Follow-on Equity Offering in the amount of INR 490.986666 million.

Company Secretary has left the company

New 90-day low: ₹3.40

Insider recently sold ₹31m worth of stock

New 90-day low: ₹5.00

Vikas Multicorp Limited (BSE:542655) agreed to acquire an unknown stake in Advik Laboratories Limited (BSE:531686) from Advik's promoters.

Vikas Multicorp Limited to Report Q3, 2021 Results on Jan 12, 2021

New 90-day low: ₹6.65

Investors Who Bought Vikas Multicorp (NSE:VIKASMCORP) Shares A Year Ago Are Now Up 130%